You are now accessing the company's Annual Review 2004.
The Annual Review is a summary report on the full year to 31st December 2004, intended for the investor not needing the full detail of the Annual Report. As a summary report, the Annual Review does not contain sufficient information to allow as full an understanding of the results and state of affairs of the Group as is provided by the full Annual Report.
Forward-looking statements
Under the 'safe harbor' provisions of the US Private Securities
Litigation Reform Act of 1995, the company cautions investors
that any forward-looking statements or projections made by the
company, including those made in the Annual Review, are subject
to risks and uncertainties that may cause actual results to differ
materially from those projected. Factors that may affect the
Group's operations are described under Risk Factors in the Operating
and Financial Review in the company's Annual Report on Form 20-F
for 2004, filed with the US Securities and Exchange Commission.
Updated 17 March, 2005 - © 2005 GlaxoSmithKline - All Rights Reserved
Back to top